Moon Capital
Our archive holds 5 letters from Moon Capital, behind 3 investment theses and positions in 5 companies. Every quote below is copied verbatim from the letter it came from.
Get an email when this fund publishes its next letter
What they bought and sold · 2 moves
- New positionZoetisJune 2026
“We added one new stock to the portfolio last quarter, Zoetis.”
Read the letter - ExitedDaVitaJune 2026
“During the second quarter, we exited our position in the kidney dialysis services company DaVita.”
Read the letter
Companies held · 5
Every company Moon Capital has disclosed a position in across our archive, with the letter that last mentioned it.
Theses · 3
- June 2026
DaVita is a kidney dialysis services company whose durable cash generation and buyback-driven per-share value creation were the original investment case.
Read the full thesis - June 2026
Zoetis is the world's largest pure-play animal health company, owned for its dominant competitive position, strong margins, durable growth prospects, and attractive valuation.
Read the full thesis - December 2025
Molina Healthcare is a Medicaid-focused managed care provider viewed as a mispriced compounder with temporary margin pressure, strong operational outperformance, and substantial upside as rates reset, earnings normalize, and valuation multiples potentially expand.
Read the full thesis
Letter archive · 5
Get Moon Capital’s next letter the day it lands
We track Moon Capital alongside hundreds of other managers, read every letter, and pull out what they bought and sold. Warren AI reads the whole archive for you.
View plans→